Loading...

Efficacy and Safety of Nivolumab in Patients with Advanced Non-small-cell Lung Cancer and Poor Performance Status

Background: Nivolumab efficacy in patients with non-small-cell lung cancer (NSCLC) and performance status (PS) of 2-4 is unclear. We aimed to compare survival, treatment efficacy, and safety in patients with NSCLC with poor PS who received nivolumab plus best supportive care (BSC) with those in pati...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Cancer
Main Authors: Katsura, Hideyuki, Suga, Yukio, Araya, Tomoyuki, Kita, Toshiyuki, Yoneda, Taro, Tanaka, Nobuyoshi, Kawabata, Ayumi, Ishita, Sotoki, Mase, Hiroki
Format: Artigo
Sprog:Inglês
Udgivet: Ivyspring International Publisher 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6584408/
https://ncbi.nlm.nih.gov/pubmed/31258716
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.31217
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!